Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.17%)
As of: Sep 4, 2026 · 3:10 PM EDT

Compugen (CGEN) Operating Margin (QoQ) (2009 - 2026)

Analysis

Compugen (CGEN) Operating Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Compugen 241.50 Mn 155.89 Mn -92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -144,709.00
Mar 31, 2026 33,115.00
Dec 31, 2025 50,063.00
Sep 30, 2025 158,889.00
Jun 30, 2025 -237,384.00
Mar 31, 2025 87,626.00
Dec 31, 2024 -53,494.00
Sep 30, 2024 33,057.00
Jun 30, 2024 -63,618.00
Dec 31, 2016 -510,348.00
Sep 30, 2016 -996,853.00
Jun 30, 2016 812,581.00
Mar 31, 2016 -952,996.00
Dec 31, 2015 301,047.00
Sep 30, 2015 9,872.00
Jun 30, 2015 -188,558.00
Mar 31, 2015 -121,534.00
Dec 31, 2014 25,033.00
Sep 30, 2014 -9,840.00
Jun 30, 2014 -1,371.00